|
Schlusskurs
Andere Börsenplätze
|
% 5 Tage | Veränd. 1. Jan. | ||
| 1’908’000.00 KRW | +2.64% |
|
+90.80% | +90.80% |
Hauptkonkurrenten
| Umsatz (Y-1) | Nettogewinn (Y-1) | EBIT-Marge (Y-1) | ROE (Y-1) | ROA (Y-1) | Verschuldungsgrad (Y-1) | ||
|---|---|---|---|---|---|---|---|
| 3.08 Mrd. | 23.82% | 29.03% | 10.45% | 6.49% | 0.1x | ||
| 14.2 Mrd. | 31.07% | 36.7% | 19.23% | 15.02% | -1.11x | ||
| 6.37 Mrd. | 17.31% | 13.59% | 11.21% | 6.48% | 0.99x | ||
| 15.56 Mrd. | 19.3% | 28.72% | 16.36% | 7.75% | 1.74x | ||
| 9.68 Mrd. | 16.87% | 31.16% | 10.36% | 5.95% | 1.06x | ||
| 4.24 Mrd. | 0.77% | 9.76% | 5.27% | 3.72% | -4.29x | ||
| 1.29 Mrd. | -1% | -8.02% | -0.74% | -0.45% | -11.4x | ||
| 69.63 Mio. | 59.01% | 24.7% | 28.77% | 18.72% | -6.16x | ||
| 222 Mio. | -241.44% | -267.22% | 35.11% | -73.11% | -1.77x | ||
| 681 Mio. | -10.97% | -17.14% | -8.58% | -7.13% | 8.63x | ||
| 3.24 Mrd. | -110.04% | -121.91% | -28.77% | -21.87% | 1.87x | ||
| 2.35 Mrd. | 14.93% | 22.42% | 10.9% | 5.41% | 1.59x | ||
| 2.85 Mrd. | 14.96% | 16.97% | 8.05% | 6.17% | -0.93x | ||
| 10.9 Mio. | -2’957.71% | -3’477.43% | -33.47% | - | 3.99x | ||
| 1.25 Mrd. | 22.95% | 28.06% | 14.19% | 8.74% | 0.28x | ||
| 386 Mio. | -74.47% | -72.74% | -231.63% | -49.66% | 0.49x | ||
| 308 Mio. | 4.73% | 4.18% | 0.85% | - | -5.29x | ||
| 7.47 Mrd. | 2.18% | 18.81% | 2.79% | 0.74% | 5.16x | ||
| 291 Mio. | 30.69% | 22.61% | 10.34% | - | -8.45x | ||
| Durchschnitt | 3.87 Mrd. | -165.11% | -193.57% | -6.28% | -4.19% | -0.71x | |
| Gewichteter Durchschnitt nach Marktkapitalisierung | 6.86 Mrd. | -65.79% | -77.1% | 5.75% | 2.87% | -0.47x |
- Börse
- Aktien
- A207940 Aktie
- Sektor Samsung Biologics Co.,Ltd.
- Finanzielle Vergleiche
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
MarketScreener is also available in this country: United States.
Switch edition
Bei der aktuellen länderspezifischen Edition bleiben
















